Neratinib
698387-09-6 Basic informationMore
- Product Name:Neratinib
- Synonyms: Neratinib(HKI-272) (2E)-N-[4-[[3-chloro-4-(2-pyridinylMethoxy)phenyl]aMino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(diMethylaMino)-2-butenaMide neratinib (E)-N-[4-[3-Chloro-4-[(2-pyridinyl)methoxy]anilino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide Unii-jjh94R3pwb (2e)-n-(4-((3-chloro-4-((pyridin-2-yl)Methoxy)phenyl)aMino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(diMethylaMino)but-2-enaMide neratinib HKI-272 Neratinib
- CAS:698387-09-6
- MF:C30H29ClN6O3
- MW:557.04
- EINECS:811-237-1
- Mol File:698387-09-6.mol
USE
Neratinib developed by US Wyeth company is an irreversible epidermal growth factor receptor(EGFR) inhibitor. It is a multiple target point of small molecule tyrosine kinase inhibitors to HER 2 and HER1 after Lapatinib, and is an irreversible ErbB receptor tyrosine kinase inhibitor. Neratinib could selectively inhibit HER-1 and HER-2 of EGFR family(IC50 was 92 nmol/L and 59 nmol/L, respectively). Clinical research showed that Neratinib exerted significant therapeutic effect on non-small cell lung cancer, colon cancer, and breast cancer. <br/>
The phaseⅡclinical trial indicated that Neratinib showed good efficacy and tolerance to HER-2 positive patients with advanced breast cancer who had been received or not Trastuzumab treatment.<br/>
The phase Ⅲ breast cancer clinical trial was complete in September 2014. The data indicated that the efficacy of Neratinib was better than Roche's Herceptin in treatment of HER-2 positive early breast cancer.<br/>
The above information is edited by the Chemicalbook of Liu Yujie.
Lastest Price from Neratinib manufacturers
- Neratinib
- US $0.00-0.00/kg
- CAS:698387-09-6
- Min. Order: 1kg
- Purity: 99%,single impurity<0.1
- Supply Ability: 1 ton
- 2024-11-21
- Neratinib (HKI-272)
- US $0.00 /g
- CAS:698387-09-6
- Min. Order: 1g
- Purity: 98% HPLC
- Supply Ability: 1KG
- 2024-11-19
Browse by Nationality 698387-09-6 Suppliers >Global suppliers
Beijing (14) Shanghai (92) Tianjin (1) Chongqing (4) Sichuan (3) Guangdong (21) Zhejiang (26) Fujian (1) Hunan (3) Hubei (54) Shandong (17) Henan (8) Hebei (5) Liaoning (1) Anhui (9) Jiangsu (47) Jiangxi (6) Shaanxi (8) Hong Kong (2) Other (1) Member (316) All (323)
Please select the suppliers
Recommend You Select Member Companies
Recommend You Select Member Companies
- Company Name:Shanghai jing Hao pharmaceutical technology co., LTD
- Tel:021-68900963 15618693615
- Products Intro:Product Name:Neratinib
CAS:698387-09-6
Purity:99.0% Package:100kg;1kg;10kg Remarks:1g More... - CB Index:58
- Related Information:Catalog(287)
- Company Name:Jiangxi Puxin Biotechnology Co., Ltd
- Tel:15867635987 15867635987
- Products Intro:Product Name:Neratinib
CAS:698387-09-6
Purity:99% Package:1kg - CB Index:58
- Related Information:Catalog(285)
- Company Name:J & K SCIENTIFIC LTD.
- Tel:010-82848833 400-666-7788
- Products Intro:Product Name:Neratinib, 99%, a highly selective HER2 and EGFR inhibitor
CAS:698387-09-6
Purity:99% Package:10MG;250MG;50MG More... - CB Index:76
- Related Information:Catalog(96815)
- Company Name:Chembest Research Laboratories Limited
- Tel:+86-21-20908456
- Products Intro:Product Name:Neratinib (HKI-272)
CAS:698387-09-6
Purity:98%+ Package:100mg;500mg;1g;5g;10g;50g;100g Remarks:C13927 More... - CB Index:61
- Related Information:Catalog(6005)
- Company Name:Jia Xing Isenchem Co.,Ltd
- Tel:0573-85285100 18627885956
- Products Intro:CAS:698387-09-6
Purity:98% (HPLC or GC) Package:25g,100g,500g;1kg More... - CB Index:66
- Related Information:Catalog(9413)